• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Infect Dis . Cycle Threshold Values as Indication of Increasing SARS-CoV-2 New Variants, England, 2020-2022

tetano

Editor, Senior Moderator
Emerg Infect Dis


. 2023 Sep 7;29(10).
doi: 10.3201/eid2910.230030. Online ahead of print.
Cycle Threshold Values as Indication of Increasing SARS-CoV-2 New Variants, England, 2020-2022

Rebecca E Harrison, Ahmed Hamada, Nujcharee Haswell, Aigul Groves, Karina-Doris Vihta, Kerry Cella, Sarah Garner, Ann Sarah Walker, Anna C Seale
Abstract

Early detection of increased infections or new variants of SARS-CoV-2 is critical for public health response. To determine whether cycle threshold (Ct) data from PCR tests for SARS-CoV-2 could serve as an early indicator of epidemic growth, we analyzed daily mean Ct values in England, UK, by gene target and used iterative sequential regression to detect break points in mean Ct values (and positive test counts). To monitor the epidemic in England, we continued those analyses in real time. During September 2020-January 2022, a total of 7,611,153 positive SARS-CoV-2 PCR test results with Ct data were reported. Spike (S) gene target (S+/S-)-specific mean Ct values decreased 6-29 days before positive test counts increased, and S-gene Ct values provided early indication of increasing new variants (Delta and Omicron). Our approach was beneficial in the context of the first waves of the COVID-19 pandemic and can be used to support future infectious disease monitoring.

Keywords: 2019 novel coronavirus disease; COVID-19; England; SARS-CoV-2; United Kingdom; coronavirus disease; polymerase chain reaction; quantitative real-time PCR; respiratory infections; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.
 
Back
Top Bottom